Our Mission

Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.

Clinical Trials

ALISCA™-Breast1 Active Sites

Puma anticipates opening the ALISCA™-Breast1 trial at approximately 50 study sites within the United States and Europe. Below is a list of sites currently open to enrollment as of 04FEB2025. Please note study site availability for enrollment is subject to change without notice. Please contact Puma at clinicaltrials@pumabiotechnology.com should you have any questions regarding open sites.

Center Name
City
State
Phone
Birmingham
AL
(205) 856-8488
Phoenix
AZ
(480) 342-6057
Los Angeles
CA
(213) 977-1214
New Haven
CT
(203) 785-4095
Jacksonville
FL
(904) 953-2000
Rochester
MN
(507) 284-2511
Saint Louis
MO
(314) 362-9303
Springfield
MO
(417) 882-4880
Maumee
OH
(567) 402-4501
Horsham
PA
(215) 706-2034
Dallas
TX
(214) 370-1000